Navigation Links
Gallup, Healthways Announce Global Well-Being Index(SM)
Date:3/6/2008

ted States, and is expected to be extended globally over the next decade.

Initial results from the first 50,000 completed surveys with American households reveal such findings as:

-- Friends and family helped individuals improve or maintain their health

53% of the time, almost as frequently as physicians who were cited 59%

of the time

-- Eighteen percent of full-time workers indicated that they currently

care for a disabled or elderly family member, relative or friend

-- More than one-third of unemployed individuals looking for work smoke as

compared to about one-fifth of individuals employed on a full-time

basis

"Healthways has long believed that a person's state of health affects not only direct healthcare costs, but also impacts their ability to be productive in the work environment," Leedle said. "The index will enable employers and community leaders to objectively assess the health of their population and access solutions that maintain health, modify risk factors and focus on the evidenced-based care necessary for those with chronic and persistent conditions."

The Gallup-Healthways Well-Being Index will provide cities, states and countries, as well as employers, families and individuals with objective information that shows their well-being score, how it compares to benchmarks, why that is, as well as things they can do and solutions they can employ to change it.

"Employers will now be able to measure the well-being of their workforce and families anywhere in the world. We envision that the Gallup-Healthways Well-Being Index will be an important, if not a leading factor in a company's decisions about health benefits, work environment and corporate culture, as well as providing a new, critical data point about site selection for a new plant or facility," Leedle added. "Organizations have long made such decisions based on workforce, transportation systems and educat
'/>"/>

SOURCE Gallup
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Healthways Enters German Healthcare Market
2. Derma Sciences Announces Numerous Clinical Presentations on MEDIHONEY(TM) Wound & Burn Dressings at Upcoming SAWC Conference
3. Milestone Scientific Announces Chicago Dental Societys 143rd Midwinter Meeting Proved Successful
4. Zounds Hearing Enters Moorestown and Announces $225,000 Hearing Partnership With Twilight Wish Foundation
5. Pregis Announces Investor Conference Call to Review 2007 Fourth Quarter and Full Year Financial Results
6. Genoptix Announces Participation at Cowen and Company 28th Annual Health Care Conference
7. SXC Health Solutions Announces 2007 Fourth Quarter and Year-end Financial Results
8. The Pennsylvania Breast Cancer Coalition Announces Last Chance to Enter Makeover for Mom Contest
9. Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results
10. Trubion Announces Presentations at Upcoming Investor Conferences
11. Martek Announces First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)...linical trial results could lead to availability o...eatment for deep lines and wrinkles by 2009. , ... 24, 2008 -- Gel-Del Technologies , a St. Paul, M... that it has concluded clinical trials of CosmetaL...als say holds potential to be a more effective alt...
(Date:7/24/2008)...ll/ --, Key Highlights, Misys plc (LSE: MSY) del...sing targets for the next phase of the turnaround....%, bringing Group operating profit(2) to GBP81m,3...trategy and entering,into the next phase of the tu...o view the Multimedia News Release, please click:,...
(Date:7/23/2008)...wire/ -- MediVoice(R), LLC, the,world,s first mobi...escribing, has formed a strategic partnership with... web-based, patient-centered health record,managem...e and market its,mobile voice-activation solution ...., "MediVoice is pleased to develop a strategic p...
(Date:7/23/2008)..., July 23 /PRNewswire-FirstCall/ - Cardiome Pharma...t it has entered into an,agreement with CR Intrins...,CR Intrinsic Investors, LLC, an affiliate of S.A....ertible preferred shares for gross proceeds of,US$... for general corporate,purposes, costs associated ...
Breaking Medicine News(10 mins):Health News:Clinical Trial Concluded For New Wrinkle Treatment 2Health News:Clinical Trial Concluded For New Wrinkle Treatment 3Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 2Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 3Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 4Health News:MediVoice(R) Partners With VisionTree(R) to Integrate Its Voice-Activated e-Prescribing Solution Into VisionTree's VTOC(TM) Web-Based Patient Management System 2Health News:MediVoice(R) Partners With VisionTree(R) to Integrate Its Voice-Activated e-Prescribing Solution Into VisionTree's VTOC(TM) Web-Based Patient Management System 3Health News:Cardiome Announces Preferred Share Financing 2Health News:Cardiome Announces Preferred Share Financing 3
...ndia has declined over the century from 972 in 190... to 933 in 2001. In contrast, the child sex rati...rls per thousand boys against 945 recorded in 1991...tio is concerned, it is 1.01 male (s)/females as i...
...ntessentially Indian puff, has become a victim of ...outhern districts of Tamil Nadu going on strike. ...wrapped in leaf, from Tirunelveli, Tuticorin and K...this weekend to protest the union health ministry ...
...Democratic Front (LDF) government, set to mark its...at it is to blame for the deaths of 38 newborns in...fection in the labour room of the Sree Avittam Tir...the last two months. A court has charged Health M...
...is of concern as it is a reflection of the prevale...s and the extent of transmission of TB infection ...orted under the programme are of paediatric age gr...ntage of paediatric cases reported at national lev...
Other Medicine News:Health News:Bidi Workers Protest Against Using Skull and Crossbones Sign on Packets 2
(Date:7/22/2008)...y and Efficacy of Treating Patients with ...CO, and YONGIN-SI, South Korea, July 22 /PRNewswir..., Ontario), and its South,Korean partner Green Cro...,a Phase I clinical trial of its first-in-class le...s well-tolerated and resulted in clear,anti-cancer...
(Date:7/22/2008)...(R) and Apidra(R) Resulted in Significant, Reducti...ver the Algorithm ... Results from the "Adjust to,Target in Type 2 Diab...rate,Counting for Adjustment of Mealtime Insulin G...abetes Association,s (ADA) medical journal,Diabet...
(Date:7/22/2008)... July 22 /- Hyperion,Therapeutics, In...nrollment,in its Phase 1/2 clinical trial to evalu...g effects of HPN-100 (formally called GT4P) versus...ith urea cycle disorders,(UCD). The company plans ...,of this year., (Logo: http://www.newscom.com/cg...
(Date:7/22/2008)...Columbia University Medical Center Based on ...ogy, The Test Differentiates Squamous From Non-S...ifying Squamous-Cell Carcinoma of the Lung With ...90 Percent,This is the First CLIA Approved Test Wh...iomarkers for Accurate Diagnosis of Lung Cancer, ...
Breaking Medicine Technology:Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5NBTY to Webcast Presentation at Bank of America Consumer Conference 3A Announces Preliminary Sales and the Repurchase of 6 1 Million Shares 13854 1NBTY to Webcast Presentation at Bank of America Consumer Conference 3A Announces Preliminary Sales and the Repurchase of 6 1 Million Shares 13854 2NBTY to Webcast Presentation at Bank of America Consumer Conference 3A Announces Preliminary Sales and the Repurchase of 6 1 Million Shares 13854 3Cepheid to Present at Cowen and Companys 28th Annual Healthcare Conference 3809 1Cepheid to Present at Cowen and Companys 28th Annual Healthcare Conference 3809 2More than Seventy Percent of Top US Hospitals Control Patient Temperature with High Tech Arctic Sun 28TM 29 13849 1More than Seventy Percent of Top US Hospitals Control Patient Temperature with High Tech Arctic Sun 28TM 29 13849 2AVMA 3A Keep Pets Safe This Easter 13847 1AVMA 3A Keep Pets Safe This Easter 13847 2
...w Dissociation from HCV,Protease , ,WASHINGTON, Ma...etwork/ -- InterMune, Inc. (Nasdaq: ITMN) today pr...titis C virus (HCV) NS3/4A,protease inhibitor, ITM...e Disease Week (DDW) meeting being held May 19-24 ...ct #M1816) examined,ITMN-191 potency and binding k...
... FDA for long-term maintenance,treatment of COPD b...ed formoterol fumarate provides improved lung func... patient quality of,life, and positive safety prof... Data presented at the,International Conference of...hat Perforomist (formoterol fumarate) Inhalation,S...
Other Medicine Technology:InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive,Disease Week Meeting 2InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive,Disease Week Meeting 3InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive,Disease Week Meeting 4InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive,Disease Week Meeting 5Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 2Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 3Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 4Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 5Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 6Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 7
Anti Gliadin IgA Enzyme Immunosay for quantitative determination of Gliadin-IgG antibodies in serum.
...igned as a high throughput primary or backup instr...r offers performance and reliability equal to or g...advanced technology of the AUTION JET AJ-4270 and ...ate results, limiting interference from elevated p...
Assay uses highly specific rabbit anti-estriol antibody reparation - negligible cross-reactivity with other estrogen metabolites. Excellent assay precision and reproducibility. Superior sensitivity
...rone Sulfate (E1S) is the most abundant circulatin... men [1,2]. Estrone Sulfate is a major metabolite ...fe in blood [2,3]. In premenopausal women, estrone...e and estradiol, rising gradually during the folli...
Medicine Products: